Offsets |
Apr. 10, 2026
USD ($)
shares
|
|---|---|
| Offset: 1 | |
| Offset Payment: | |
| Offset Claimed | true |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | Autolus Therapeutics plc |
| Form or Filing Type | F-3 |
| File Number | 333-264304 |
| Initial Filing Date | Apr. 15, 2022 |
| Fee Offset Claimed | $ 8,323.08 |
| Security Type Associated with Fee Offset Claimed | Equity |
| Security Title Associated with Fee Offset Claimed | American Depositary Shares (ADSs) |
| Unsold Securities Associated with Fee Offset Claimed | shares | 21,250,917 |
| Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | $ 29,113,756.29 |
| Termination / Withdrawal Statement | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended. The calculation of the proposed maximum aggregate offering price of the ADSs is based on the average of the high and low price for ADSs on April 7, 2026, as reported on the Nasdaq Global Select Market. In connection with the registration of the Unsold Blackstone Securities on the 2022 Registration Statement, the registrant paid registration fees of $8,323.08. No additional registration fees were paid for the Unsold Blackstone Securities in connection with the 2025 Registration Statement, which was a post-effective amendment to the 2022 Registration Statement and contained a combined prospectus pursuant to Rule 429 for the Unsold Blackstone Securities and the Unsold BioNTech Securities. |
| Offset: 2 | |
| Offset Payment: | |
| Offset Claimed | true |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | Autolus Therapeutics plc |
| Form or Filing Type | S-3 |
| File Number | 333-278320 |
| Initial Filing Date | Mar. 28, 2024 |
| Fee Offset Claimed | $ 2,004.10 |
| Security Type Associated with Fee Offset Claimed | Equity |
| Security Title Associated with Fee Offset Claimed | American Depositary Shares (ADSs) |
| Unsold Securities Associated with Fee Offset Claimed | shares | 33,333,333 |
| Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | $ 45,666,666.21 |
| Termination / Withdrawal Statement | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended. The calculation of the proposed maximum aggregate offering price of the ADSs is based on the average of the high and low price for ADSs on April 7, 2026, as reported on the Nasdaq Global Select Market. In connection with the registration of the Unsold BioNTech Securities on the 2024 Registration Statement, the registrant paid registration fees of $30,848.40. No additional registration fees were paid for the Unsold BioNTech Securities in connection with the 2025 Registration Statement, which was a post-effective amendment to the 2024 Registration Statement and contained a combined prospectus pursuant to Rule 429 for the Unsold Blackstone Securities and the Unsold BioNTech Securities. |
| Offset: 3 | |
| Offset Payment: | |
| Offset Claimed | false |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | Autolus Therapeutics plc |
| Form or Filing Type | F-3 |
| File Number | 333-264304 |
| Filing Date | Apr. 15, 2022 |
| Fee Paid with Fee Offset Source | $ 8,323.08 |
| Offset: 4 | |
| Offset Payment: | |
| Offset Claimed | false |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | Autolus Therapeutics plc |
| Form or Filing Type | S-3 |
| File Number | 333-278320 |
| Filing Date | Mar. 28, 2024 |
| Fee Paid with Fee Offset Source | $ 30,848.40 |